Literature DB >> 15704869

Relationship between the clinical-neurophysiologic pattern, disability, and quality of life in adolescents with spina bifida.

Luca Padua1, Claudia Rendeli, Emanuele Ausili, Irene Aprile, Pietro Caliandro, Pietro Tonali, Elio Salvaggio.   

Abstract

A number of studies have focused on quality of life in children with spina bifida, concentrating for the most part on younger children. We assessed health-related quality of life and disability in adolescents with spina bifida and correlated these with the clinical and neurophysiologic picture. Twelve consecutive spina bifida cases were evaluated through a multiperspective protocol by means of (1) clinical and neurophysiologic assessment, (2) a self-administered questionnaire for general health--Short Form-36 (SF-36)--and (3) standardized disability measurements (Functional Independence Measure, Barthel Index, Deambulation Index). Relationships between disability measurement, the adolescents' perspective, and conventional clinical and neurophysiologic assessment were evaluated. The Functional Independence Measure is strongly related to the clinical measurement of muscle strength (P < .03, r > .6). The Barthel Index and Deambulation Index are related to clinical measurement of muscle strength (P < .03, r > .6), as well as to electromyographic findings in the proximal muscles of inferior limbs (P < .05, r > .6). Although the function of lower limb muscles, especially the proximal muscles, is closely related to impairment of physical aspects of quality of life, it is only partially related to the mental aspects (P < .03, r > .6). The findings at clinical examination, especially proximal deficit of inferior limbs, were usually related to higher disability and lower physical aspects of quality of life. The multiperspective evaluation of adolescents with spina bifida shows a high correlation between conventional neurologic-neurophysiologic measurements and the adolescents' own perspective of their quality of life. Our data demonstrated that the conventional clinical and neurophysiologic measurements are useful not only because they provide a measure of lower limb impairment but also because they appear to be related to physical aspects of the adolescent's quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15704869     DOI: 10.1177/08830738040190120801

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  Activity level, functional health, and quality of life of children with myelomeningocele as perceived by parents.

Authors:  Ann Flanagan; Marianne Gorzkowski; Haluk Altiok; Sahar Hassani; Kwang Woo Ahn
Journal:  Clin Orthop Relat Res       Date:  2011-05       Impact factor: 4.176

2.  Quality of life of very young spina bifida patients after initial surgical treatment.

Authors:  Kirtikumar Jagdish Rathod; J K Mahajan; Rizwan Ahmad Khan; K L N Rao
Journal:  Childs Nerv Syst       Date:  2012-01-17       Impact factor: 1.475

3.  Audiological evaluation in children affected by myelomeningocele.

Authors:  Pasqualina Maria Picciotti; M Battista; M Pandolfini; G Paludetti; E Ausili; C Romagnoli; C Rendeli
Journal:  Childs Nerv Syst       Date:  2015-09-08       Impact factor: 1.475

4.  Impact of spinal cord dysfunction and obesity on the health-related quality of life of children and adolescents.

Authors:  Richard Ted Abresch; Dawn A McDonald; Lana M Widman; Katrina McGinnis; Kathryn J Hickey
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

5.  Assessment on self-care, mobility and social function of children with spina bifida in Turkey.

Authors:  Hulya Sirzai; Beril Dogu; Selamet Demir; Figen Yilmaz; Banu Kuran
Journal:  Neural Regen Res       Date:  2014-06-15       Impact factor: 5.135

6.  Clinical and Environmental Predictors of Health-Related Quality of Life in Lithuanian Children and Adolescents with Spina Bifida: A Cross-Sectional Analysis of a Nationally Represented Sample.

Authors:  Indrė Bakanienė; Audronė Prasauskienė
Journal:  Medicina (Kaunas)       Date:  2018-08-28       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.